These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19655533)

  • 1. Big pharma, big dealing. Bristol-Myers to buy Medarex; Wyeth sale approved.
    Galloro V
    Mod Healthc; 2009 Jul; 39(30):14. PubMed ID: 19655533
    [No Abstract]   [Full Text] [Related]  

  • 2. Lilly deal's timing drew FTC notice.
    Scott L
    Mod Healthc; 1994 Oct; 24(43):8. PubMed ID: 10138136
    [No Abstract]   [Full Text] [Related]  

  • 3. Lilly purchase of PCS awaits FTC clearance.
    Scott L
    Mod Healthc; 1994 Oct; 24(44):29. PubMed ID: 10138146
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharma spends big to buy influence.
    Nat Med; 2010 Mar; 16(3):243. PubMed ID: 20208486
    [No Abstract]   [Full Text] [Related]  

  • 5. Sizing Up the Mega-Mergers Through Prisms and Microscopes.
    Kirkner RM
    Manag Care; 2016 Feb; 25(2):13-4. PubMed ID: 27008828
    [No Abstract]   [Full Text] [Related]  

  • 6. Too big? Caremark, AdvancePCS getting close look from feds.
    Becker C
    Mod Healthc; 2004 Jan; 34(2):14, 16. PubMed ID: 14959629
    [No Abstract]   [Full Text] [Related]  

  • 7. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotech as Bush bows out.
    Lorenzo A
    Nat Biotechnol; 2008 Jan; 26(1):15-8. PubMed ID: 18183006
    [No Abstract]   [Full Text] [Related]  

  • 9. Physician integration is back--and more important than ever.
    Sanderson B; Rice B; Fox M
    Healthc Financ Manage; 2008 Dec; 62(12):64-71. PubMed ID: 19069324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The patentability of antibodies in the United States.
    Lu DL; Collison AM; Kowalski TJ
    Nat Biotechnol; 2005 Sep; 23(9):1079-80. PubMed ID: 16151395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
    Stipp D
    Fortune; 2002 Apr; 145(8):144-6, 148, 150. PubMed ID: 11961884
    [No Abstract]   [Full Text] [Related]  

  • 12. Tax reform fears driving big pharma mergers.
    Kutscher B
    Mod Healthc; 2014 Jul; 44(29):24-6. PubMed ID: 25189018
    [No Abstract]   [Full Text] [Related]  

  • 13. India's IP snub.
    Jayaraman KS
    Nat Biotechnol; 2008 Apr; 26(4):362. PubMed ID: 18392000
    [No Abstract]   [Full Text] [Related]  

  • 14. In line for concessions? Markup possible in Anthem-Wellpoint merger plan.
    Benko LB
    Mod Healthc; 2004 Nov; 34(46):10. PubMed ID: 15609726
    [No Abstract]   [Full Text] [Related]  

  • 15. Big pharma swallows biotech's pride.
    Huggett B
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract]   [Full Text] [Related]  

  • 16. Trade group says thwarting drug counterfeiters remains challenging.
    Traynor K
    Am J Health Syst Pharm; 2007 Dec; 64(24):2532, 2534. PubMed ID: 18056936
    [No Abstract]   [Full Text] [Related]  

  • 17. Mixing drugs. Latest pharma deals unlikely to affect prices: experts.
    Galloro V
    Mod Healthc; 2009 Mar; 39(11):14. PubMed ID: 19415830
    [No Abstract]   [Full Text] [Related]  

  • 18. The big deals wheel again.
    Kiviat B
    Time; 2006 Aug; 168(6):50-1. PubMed ID: 16958206
    [No Abstract]   [Full Text] [Related]  

  • 19. Health care profession beware! The securities laws may bite you.
    Rowe RH
    Benders Health Care Law Mon; 1996 Jan; ():13-5. PubMed ID: 10158207
    [No Abstract]   [Full Text] [Related]  

  • 20. Stark rules. Purchases that pass muster.
    Terry K
    Med Econ; 2006 Dec; 83(24):44-6, 49. PubMed ID: 17249392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.